STAT July 31, 2024
Lev Facher

The Biden administration isn’t doing enough to ensure people living in recovery housing have access to gold-standard addiction medications like methadone and buprenorphine, according to a coalition of health care, harm reduction, and addiction recovery groups.

The discrimination that people often face when seeking treatment using methadone or buprenorphine, the groups say, is especially pronounced within recovery housing facilities, which typically offer lodging coupled with counseling and other social services. Many facilities have historically refused to admit people taking addiction medications, effectively treating their use as akin to using heroin or fentanyl. While attitudes have evolved and outright bans on methadone or buprenorphine have become less common, the practice persists.

Failing to offer all forms of medication-assisted treatment...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Mental Health, Patient / Consumer, Provider
What to know about Trump's surgeon general nominee
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Trump's pick for CDC director: 10 things to know
Trump tariffs could drive up generic drug costs: 5 takeaways
Senators urge Congress to avert Medicare physician pay cut

Share This Article